Trial Profile
The Rimonabant in treatment of Prediabetes Study: a randomised clinical trial of Rimonabant in the treatment of patients with Prediabetes
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 01 Mar 2019
Price :
$35
*
At a glance
- Drugs Rimonabant (Primary)
- Indications Glucose intolerance
- Focus Therapeutic Use
- Acronyms TRIMTOP
- 01 Mar 2019 Status changed from completed to discontinued.
- 24 Sep 2010 Actual end date (27 Sep 2008) indentified as reported by United Kingdom Clinical Research Network record.
- 24 Sep 2010 Status changed from suspended to completed as reported by United Kingdom Clinical Research Network record.